Publications

Maher L, Hope K, Torvaldsen S, Lawrence G, Dawson A, Wiley K, Thomson D, Hayen A, Conaty S. Influenza vaccination during pregnancy: coverage rates and influencing factors in two urban districts in Sydney. Vaccine 2013;31:5557-64. [Abstract]

Chow MY, Morrow AM, Cooper Robbins SC, Leask J. Condition-specific quality of life questionnaires for caregivers of children with pediatric conditions: a systematic review. Quality of Life Research 2013;22:2183-200. [Abstract]

Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O’Brien KL, Moore MR, the Serotype Replacement Study Group (including McIntyre P, Menzies R, Jayasinghe S) . Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Medicine 2013;10:e1001517. [Abstract]

Rashid H, Abdul Muttalif AR, Mohamed Dahlan ZB, Djauzi S, Iqbal Z, Karim HM, Naeem SM, Tantawichien T, Zotomayor R, Patil S, Schmitt HJ. The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion. Travel Medicine and Infectious Disease 2013;11:288-94. [Abstract]

Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O’Brien KL, Moore MR, the Serotype Replacement Study Group (including McIntyre P, Menzies R, Jayasinghe S) . Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Medicine 2013;10:e1001517. [Abstract]

Rashid H, Barasheed O, Booy R. Acute febrile respiratory infection symptoms in Australian Hajjis at risk of exposure to Middle East respiratory syndrome coronavirus [letter] . Medical Journal of Australia 2013;199:453 . [Abstract]

Rashid H, Barasheed O, Booy R. Acute febrile respiratory infection symptoms in Australian Hajjis at risk of exposure to Middle East respiratory syndrome coronavirus [letter] . Medical Journal of Australia 2013;199:453. [Abstract]

Mahajan D, Cook J, Dey A, Macartney K, Menzies R. Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012. Communicable Diseases Intelligence 2013;37:E130-4. [Full text]

Lambert SB, Chuk LM, Nissen MD, Nolan TM, McVernon J, Booy R, Heron L, Richmond PC, Walls T, Marshall HS, Reynolds GJ, Hartel GF, Hu W, Lai MH. Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents . Influenza and Other Respiratory Viruses 2013;7:676-85. [Abstract]

Hull B. Australian childhood immunisation coverage, 1 October to 31 December cohort, assessed as at 31 March 2013 [quarterly report]. Communicable Diseases Intelligence 2013;37:E276-7 . [Full text]